Category: ARTIFICIAL INTELLIGENCE - Page 2 - Start Medical Product Development

BPS Bioscience Licenses Monod Bio’s AI-Designed Proteins to Develop Novel Research Products and Services

October 8, 2026

SEATTLE and SAN DIEGO, Oct. 8, 2026 /PRNewswire/ — Monod Bio and BPS Bioscience today announced a non-exclusive licensing agreement covering Monod Bio’s LuxSit Pro de novo luciferase and NovoBody binding proteins. BPS plans to integrate the technologies into the development of innovative research products and services for drug discovery and life science applications.

Aevice Health gains FDA clearance for AI-powered wheeze detection software

October 6, 2026

The Class II decision-support software analyses lung sound recordings from compatible FDA-cleared electronic stethoscopes and flags recordings suggestive of wheeze for clinical review.

AIRS Medical Receives FDA Clearance for SwiftSight Body Composition

October 6, 2026

SwiftSight Body Composition is designed around a scan of less than five minutes, followed by automated AI analysis

AI May Help Catch Heart Transplant Rejection Without Biopsies

October 6, 2026

NEW YORK, Oct. 6, 2026 /PRNewswire/ — By analyzing heart rhythm recordings and blood tests, artificial intelligence may accurately flag when a transplant patient’s body starts attacking a donated heart, a new study suggests.

Wearable AI forecasts prolonged sitting in women with chronic pelvic pain

September 30, 2026

Researchers at the Icahn School of Medicine at Mount Sinai have developed an artificial intelligence (AI) approach that uses data from wearable devices to forecast upcoming periods of prolonged sitting in women with chronic pelvic pain disorders.

AI-guided light analysis could help assess skin cancer and reduce unnecessary biopsies

September 30, 2026

Skin cancer is the most common cancer in the United States and among the most common worldwide. Nearly 1.5 million new cases were diagnosed globally in 2024, including nearly 340,000 melanomas. Nonmelanoma skin cancers—primarily basal cell carcinoma (BCC) and squamous cell carcinoma (SCC)—are even more common, with 5.4 million cases diagnosed annually in the U.S.

Blog

- ARTIFICIAL INTELLIGENCE

BPS Bioscience Licenses Monod Bio’s AI-Designed Proteins to Develop Novel Research Products and Services

Aevice Health gains FDA clearance for AI-powered wheeze detection software

AIRS Medical Receives FDA Clearance for SwiftSight Body Composition

AI May Help Catch Heart Transplant Rejection Without Biopsies

Wearable AI forecasts prolonged sitting in women with chronic pelvic pain

AI-guided light analysis could help assess skin cancer and reduce unnecessary biopsies

Smartphone-enabled AI tool can detect widely underdiagnosed heart condition

Healthcare Triangle, Inc Signs MOU to Bring AI-Enabled Humanoid Nursing Robots to Hospitals in North America

Elsevier launches ClinicalKey Nursing AI, a new evidenced-based clinical AI solution built specifically for nurses

New AI tool can predict where glioblastoma is most likely to return after initial surgery